Form 4 Tracker
Charles W Newhall III

Director · 2 filings · Latest: Feb 24, 2026

SUPERNUS PHARMACEUTICALS, INC.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
SUPN
CHARLES NEWHALLOct 9, 2025
Proposed Sale
$48.0025,000$1.2M
SUPN
CHARLES NEWHALLAug 25, 2025
Proposed Sale
$44.884,588$205.9K
SUPN
CHARLES NEWHALLAug 22, 2025
Proposed Sale
$43.321,412$61.2K
SUPN
CHARLES NEWHALLNov 11, 2024
Proposed Sale
$36.2410,700$387.8K